- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT03452241
Long-term Follow-up Study of Substance Abuse Screening and Intervention in Multi Primary Care Centers
19. marts 2020 opdateret af: DU, Jiang, Shanghai Mental Health Center
The purpose of this research is to improve the ability of primary medical staffs in screening and intervention for alcohol, benzodiazepines, and other illicit drug use.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
In order to reduce the social and personal harm caused by drugs, it is urgent to strengthen the ability of the primary health institutions in screening and intervention the addictive substances use.
Firstly, the investigators will invite 10 primary medical staffs and 10 experts in addition to revise the manual of Alcohol, Smoking, and Substance Use Involvement Screening Test (ASSIST) and Brief Intervention (BI).
Then, the investigators will recruit related medical staffs in five provinces to participate the training of ASSIST and BI.
Secondly, the researcher will investigate the effects of BI technology in reducing the use of addictive substances, improve the addiction related knowledge of patients through randomized controlled study.
Finally, the investigators will collect the research information, revise the manual, and promote the training.
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
480
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
-
Henan, Kina
- Henan Provincical Peoples Hospital
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
18 år til 75 år (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
- aged 18-75 years;
- the patient to the community medical institutions;
- ASSIST score is in 12-27, in a moderate risk;
- voluntary to participate;
- to agree to complete baseline interviews and follow-up studies
Exclusion Criteria:
- unable to complete the questionnaire;
- serious physical illness, action inconvenience.
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Screening
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Intervention Group
The medical staffs who received the training will use the manual of brief intervention to deliver it and other materials about the harm of substance use.
|
The medical staffs who received the training will use the manual of brief intervention to deliver BI and other materials about the harm of substance use.BI refers to a standard 15-30 minute intervention that includes a series of standard models that stimulate knowledge, motivation and behavior that reduce substance abuse.the
harm of substance use is a dedicated paper publicity handbook, written by the SHMC, detailing the hazards of substance abuse.
|
|
Andet: Control Group
The participants only receive the materials about the harm of substance use
|
The participants only receive the materials about the harm of substance use.the harm of substance use is a dedicated paper publicity handbook, written by the SHMC, detailing the hazards of substance abuse.
|
|
Eksperimentel: Intervention Group 1
The medical staffs who received the training will use the manual of brief intervention twice to deliver it and other materials about the harm of substance use.
|
The medical staffs who received the training will use the manual of brief intervention to deliver BI and other materials about the harm of substance use.BI refers to a standard 15-30 minute intervention that includes a series of standard models that stimulate knowledge, motivation and behavior that reduce substance abuse.the
harm of substance use is a dedicated paper publicity handbook, written by the SHMC, detailing the hazards of substance abuse.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change from baseline in risk behaviors at 1 and 3 month
Tidsramme: baseline, 1 and 3 month
|
Risk Behaviors will be measured by ASSIST questionnaire.
|
baseline, 1 and 3 month
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Knowledge related to Substance Use measured by Knowledge related to Addiction questionnaire
Tidsramme: baseline, 1 and 3 month
|
Knowledge related to substance use will be measured by Knowledge related to Addiction questionnaire
|
baseline, 1 and 3 month
|
|
Motivation measured by Pre-treatment Readiness Scale
Tidsramme: baseline, 1 and 3 month
|
PRSS is a 5-point scale and the highest score at any stage represents the patient at this stage.
|
baseline, 1 and 3 month
|
|
Depression measured by Self-Rating Depression Scale (SDS)
Tidsramme: baseline, 1 and 3 month
|
SDS contains 20 items and the standard total score is 53, 53-62: mild to mild depression; 63-72: moderate to severe;> 72: severe depression
|
baseline, 1 and 3 month
|
|
Anxiety measured by Self-Rating Anxiety Scale (SAS).
Tidsramme: baseline, 1 and 3 month
|
SDS contains 20 items.
According to the Chinese norm results, the standard points of the cut-off value is 50 points, of which 50-59 is divided into mild anxiety, 60-69 is divided into moderate anxiety, 70 points for severe anxiety
|
baseline, 1 and 3 month
|
|
Self-esteem measured by Self-esteem questionnaire
Tidsramme: baseline, 1 and 3 month
|
the change of self-esteem will be measured by Self-esteem questionnaire.
|
baseline, 1 and 3 month
|
|
Positive and Negative Affect measured by Positive and Negative Affect Scale (PANAS)
Tidsramme: baseline, 1 and 3 month
|
It contains 20 entries.
A high positive emotional score indicates an individual's energy, concentration, and emotional well-being while a low score indicates indifference.
Negative emotional high points that the individual subjective feeling puzzled, painful emotional state, while the score is low that calm.
|
baseline, 1 and 3 month
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Efterforskere
- Ledende efterforsker: Jiang Du, M.D, Study Principal Investigator Shanghai Mental Health Center
Publikationer og nyttige links
Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
14. april 2018
Primær færdiggørelse (Faktiske)
10. juli 2018
Studieafslutning (Faktiske)
10. marts 2020
Datoer for studieregistrering
Først indsendt
19. januar 2018
Først indsendt, der opfyldte QC-kriterier
28. februar 2018
Først opslået (Faktiske)
2. marts 2018
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
23. marts 2020
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
19. marts 2020
Sidst verificeret
1. marts 2020
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- JDu-004
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
INGEN
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Intervention Group
-
ART Fertility Clinics LLCRekrutteringVirtual reality | PatienterfaringForenede Arabiske Emirater
-
University of HullHull University Teaching Hospitals NHS TrustAfsluttetLungekræft | OverlevelseDet Forenede Kongerige
-
Universidad de GranadaUniversity of Otago; University of Jaén; University of Valencia; Ministerio... og andre samarbejdspartnereAfsluttet
-
Centro de Estudio de Estado y SociedadTrukket tilbage
-
Oregon State UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...Afsluttet
-
Arkansas Children's Hospital Research InstituteAktiv, ikke rekrutterende
-
Karadeniz Technical UniversityAfsluttetSlag | Livskvalitet | Kognitiv svækkelseKalkun
-
Mayo ClinicPfizerAfsluttetRheumatoid arthritisForenede Stater
-
University of MiamiAktiv, ikke rekrutterendeLivskvalitet | Håndteringsevne | Graft vs værtssygdom | StamcelletransplantationskomplikationerForenede Stater
-
Unity Health TorontoBoston University; Centre for Addiction and Mental Health; University of... og andre samarbejdspartnereAfsluttetNød, følelsesmæssig | Stressreaktion; Spids | Stressrespons blandt sygeplejersker under COVID-19Canada